Literature DB >> 10481972

Patient-partner satisfaction with intracavernous medication supported with oral agents in selected cases of Peyronie's disease. A ten-month follow-up study.

M Culha1, N Mutlu, O Acar, B Alici.   

Abstract

We attempted to find the most adequate treatment option for some selected cases of Peyronie's disease. Between 1993 and 1996, 38 patients with Peyronie's disease and erectile dysfunction were treated with intracavernous medication, supported with oral colchicine and vitamin E. None of the cases had severe angulation of penis and intolerable pain during erection. Quality of sexual life was assessed by CWRU questionnaire. After ten-month follow-up we found improvement in all parameters, in CWRU. The symptoms of 24 cases diminished. The 21 partners examined were also satisfied with the therapy. We conclude that intracavernous medication combined with oral agents is a useful alternative treatment in selected cases of Peyronie's disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10481972     DOI: 10.1023/a:1007193212522

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  14 in total

1.  Peyronie's disease: a study of its natural history and treatment with orthovoltage radiotherapy.

Authors:  W L Furlow; H E Swenson; R E Lee
Journal:  J Urol       Date:  1975-07       Impact factor: 7.450

2.  Pre-operative assessment of Peyronie's disease using colour Doppler sonography.

Authors:  D J Ralph; T Hughes; W R Lees; J P Pryor
Journal:  Br J Urol       Date:  1992-06

3.  The treatment of loss of penile rigidity associated with Peyronie's disease.

Authors:  R J Krane
Journal:  Scand J Urol Nephrol Suppl       Date:  1996

4.  [Treatment of peyronie's disease with para-aminobenzoacidic potassium (POTOBA) (author's transl)].

Authors:  R Hasche-Klünder
Journal:  Urologe A       Date:  1978-07       Impact factor: 0.639

5.  Patient-partner satisfaction with semirigid penile prostheses for Peyronie's disease: a 5-year followup study.

Authors:  F Montorsi; G Guazzoni; F Bergamaschi; P Rigatti
Journal:  J Urol       Date:  1993-12       Impact factor: 7.450

6.  Self-injection of papaverine and phentolamine in the treatment of psychogenic impotence.

Authors:  L A Turner; S E Althof; S B Levine; C B Risen; D R Bodner; E D Kursh; M I Resnick
Journal:  J Sex Marital Ther       Date:  1989

7.  Quality of life in patients using self-administered intracavernous injections of prostaglandin E1 for erectile dysfunction.

Authors:  S Gheorghiu; M Godschalk; A Gentili; T Mulligan
Journal:  J Urol       Date:  1996-07       Impact factor: 7.450

8.  Is colchicine effective in Peyronie's disease? A pilot study.

Authors:  E Akkus; S Carrier; J Rehman; J Breza; A Kadioglu; T F Lue
Journal:  Urology       Date:  1994-08       Impact factor: 2.649

9.  Preoperative evaluation of erectile function with dynamic infusion cavernosometry/cavernosography in patients undergoing surgery for Peyronie's disease: correlation with postoperative results.

Authors:  G H Jordan; K W Angermeier
Journal:  J Urol       Date:  1993-10       Impact factor: 7.450

10.  Evaluation of erectile dysfunction in patients with Peyronie's disease.

Authors:  J F Stecker; C J Devine
Journal:  J Urol       Date:  1984-10       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.